Publications by authors named "Yue-Fang Xu"

Aim: To investigate the impact of portal inflow on liver remnants in a stable pig model of small-for-size syndrome.

Methods: Twenty pigs underwent mesocaval shunt (MCS) surgery followed by 85%-90% hepatectomy. The control group had no shunt placement; the S1 group had portal flow maintained at an average of 2.

View Article and Find Full Text PDF

Increasing evidence shows that dysregulation of microRNAs is correlated with tumor development. This study was performed to determine the expression of miR-141 and investigate its clinical significance in pancreatic ductal adenocarcinoma (PDAC). Taqman quantitative RT-PCR was used to detect miR-141 expressions in 94 PDAC tissues and 16 nontumorous pancreatic tissues.

View Article and Find Full Text PDF

Serum and glucocorticoid-inducible kinase-like kinase (SGKL) has been identified as a new integrator that decodes lipid signals produced by the activation of phosphoinositide 3-kinase (PI3K). SGKL is activated via its lipid-binding domain (phox homology domain) in response to PI3K signaling. However, downstream targets of SGKL as well as the role of SGKL as a mediator in PI3K signaling in human tissues remain to be established.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Yue-Fang Xu"

  • - Yue-Fang Xu's research primarily focuses on the physiological and molecular mechanisms relevant to liver function and cancer biology, exploring both in vivo and in vitro models.
  • - One significant study investigated the role of portal inflow preservation during portal diversion in small-for-size syndrome, highlighting the physiological consequences for liver remnants in a controlled pig model.
  • - Additionally, Xu's work has identified the prognostic importance of microRNA-141 in pancreatic ductal adenocarcinoma, establishing its potential function as a tumor suppressor and its dysregulation in cancer progression.